Literature DB >> 8561062

Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acids.

J D Palombo1, S J DeMichele, E E Lydon, T J Gregory, P L Banks, R A Forse, B R Bistrian.   

Abstract

Dienoic eicosanoids derived from phospholipid arachidonic acid (AA) in lung and liver macrophages promote leukosequestration, thrombosis, and tissue injury. Current enteral diets (diet A) are enriched with linoleic acid (LA), a precursor of AA. Novel diets low in LA and containing eicosapentaenoic acid (EPA) and gamma-linolenic acid (GLA) foster formation of less inflammatory eicosanoids. The study objective was to assess the rapidity and extent of LA and AA displacement in vivo from alveolar macrophage (AM phi), lung, and liver Kupffer and endothelial (KE) cell phospholipids in rats fed enterally with diets enriched with 5.3% (by wt) EPA and either 1.2% or 4.6% GLA (diets B and C, respectively). After surgical placement of catheters, the rats were fed enterally and co-infused intravenously with either endotoxin or vehicle continuously for 3 or 6 d. Rats given either diet B or C had significantly lower (P < 0.01) relative percentages of AA and LA within the AM phi, lung, and KE cell phospholipids, and concomitantly higher percentages of EPA compared with rats infused with diet A after 3 d of enteral feeding irrespective of endotoxin co-infusion. Incorporation of dihomo-gamma-linolenic acid (DHGLA), the metabolite of GLA, into lung and KE phospholipids was significant in rats given diet C. Most of the changes in fatty acid composition occurred by day 3. The polyunsaturated fatty acid composition of AM phi, lung, and KE cell phospholipids can be rapidly modified by continuous short-term enteral feeding with EPA- and GLA-enriched diets irrespective of concurrent endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8561062     DOI: 10.1093/ajcn/63.2.208

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  6 in total

1.  Comparison of growth and fatty acid metabolism in rats fed diets containing equal levels of gamma-linolenic acid from high gamma-linolenic acid canola oil or borage oil.

Authors:  J D Palombo; S J DeMichele; J W Liu; B R Bistrian; Y S Huang
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  Dietary supplementation with arachidonic and docosahexaenoic acids has no effect on pulmonary surfactant in artificially reared infant rats.

Authors:  Y Y Yeh; K A Whitelock; S M Yeh; E L Lien
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

3.  A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury.

Authors:  Renee D Stapleton; Thomas R Martin; Noel S Weiss; Joseph J Crowley; Stephanie J Gundel; Avery B Nathens; Saadia R Akhtar; John T Ruzinski; Ellen Caldwell; J Randall Curtis; Daren K Heyland; Timothy R Watkins; Polly E Parsons; Julie M Martin; Mark M Wurfel; Teal S Hallstrand; Kathryn A Sims; Margaret J Neff
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

Review 4.  Omega-3 fatty acids in critical illness.

Authors:  Julie M Martin; Renee D Stapleton
Journal:  Nutr Rev       Date:  2010-09       Impact factor: 7.110

5.  Metabolism of dietary alpha-linolenic acid vs. eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia.

Authors:  J D Palombo; S J DeMichele; P J Boyce; M Noursalehi; R A Forse; B R Bistrian
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

6.  Immune Enteral Nutrition Can Improve Outcomes in Medical-Surgical Patients with ARDS: A Prospective Randomized Controlled Trial.

Authors:  Elamin M Elamin; Andrew C Miller; Sophia Ziad
Journal:  J Nutr Disord Ther       Date:  2012-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.